ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 778 filers reported holding ASTRAZENECA PLC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,478,565 | -13.3% | 20,659 | -15.9% | 1.38% | +31.5% |
| Q1 2023 | $1,704,640 | -76.8% | 24,559 | -80.6% | 1.05% | -76.5% |
| Q4 2021 | $7,360,000 | +1003.4% | 126,356 | +1037.0% | 4.45% | +700.7% |
| Q3 2021 | $667,000 | -70.1% | 11,113 | -70.2% | 0.56% | -71.0% |
| Q2 2021 | $2,234,000 | -8.7% | 37,298 | -24.2% | 1.92% | +29.6% |
| Q1 2021 | $2,446,000 | -82.2% | 49,198 | -82.1% | 1.48% | -85.2% |
| Q4 2020 | $13,746,000 | +903.4% | 274,966 | +999.9% | 9.98% | +1283.0% |
| Q3 2020 | $1,370,000 | -31.3% | 25,000 | -37.5% | 0.72% | -4.7% |
| Q4 2019 | $1,995,000 | -71.5% | 40,000 | -74.5% | 0.76% | -50.4% |
| Q3 2019 | $6,993,000 | +26.1% | 156,900 | +16.8% | 1.53% | +154.7% |
| Q2 2019 | $5,544,000 | +118.4% | 134,352 | +113.9% | 0.60% | -3.8% |
| Q1 2019 | $2,539,000 | -28.6% | 62,822 | -32.9% | 0.62% | -77.6% |
| Q4 2018 | $3,555,000 | – | 93,600 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |